Diagnostic fundus autofluorescence patterns in achromatopsia.
Fahim Abigail T, Khan Naheed W, Zahid Sarwar, Schachar Ira H, Branham Kari, Kohl Susanne, Wissinger Bernd, Elner Victor M, Heckenlively John R, Jayasundera Thiran
AI Summary
Achromatopsia patients show age-dependent FAF patterns; foveal hyperfluorescence is an early diagnostic sign, progressing to hypofluorescence with atrophy, aiding early diagnosis and tracking disease progression.
Abstract
Purpose
To describe the unique diagnostic fundus autofluorescence (FAF) patterns in patients with achromatopsia and the associated findings on optical coherence tomography (OCT).
Design
Observational case series.
Methods
We evaluated 10 patients with achromatopsia by means of best-corrected visual acuity (BCVA), ophthalmoscopy, Goldmann visual field, full-field electroretinography (ffERG), OCT, and FAF photography. FAF patterns were compared with patient age and foveal changes on OCT.
Results
Patients fell into two dichotomous age groups at the time of evaluation: six patients ranged from 11 to 23 years of age, and 3 patients ranged from 52 to 63 years of age. All patients had severely reduced photopic ffERG responses, including those exhibiting preserved foveal structure on OCT. The younger patients had absent to mild foveal atrophy on OCT, and four of the six demonstrated foveal and parafoveal hyperfluorescence on FAF. In addition, a 7-month-old child with compound heterozygous mutations in CNGA3 demonstrated similar foveal hyperfluorescence. The older patients demonstrated advanced foveal atrophy and punched-out foveal hypofluorescence with discrete borders on FAF imaging corresponding to the area of outer retinal cavitation on OCT.
Conclusions
Foveal hyperfluorescence is an early sign of achromatopsia that can aid in clinical diagnosis. In our cohort, patients with achromatopsia demonstrated age-dependent changes in FAF, which are likely to be progressive and to correlate with foveal atrophy and cavitation on OCT. This finding may be useful in charting the natural course of the disease and in defining a therapeutic window for treatment.
MeSH Terms
Shields Classification
Related Articles5
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa.
Case SeriesMulticentric Longitudinal Prospective Study in a European Cohort of MYO7A Patients: Disease Course and Implications for Gene Therapy.
Cohort StudyOcular Manifestations of ROSAH Syndrome Caused by Different Mutations of the ALPK1 Gene.
Case SeriesPCARE-Associated Retinopathy - Genetics, Clinical Characteristics, and Natural History.
Cohort StudyCharacteristics of Eyes With CRB1-Associated EOSRD/LCA: Age-Related Changes.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.